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An analysis of global HIV prevalence among
refugees, asylum seekers, and migrants, using
the US Bureau of the Census databank
W. Shandera
Baylor College of Medicine, Houston, TX, USA
Background: As a risk-factor population for HIV infection,
unsettled populations, in particular, refugees and migrants are
understudied.
Methods & Materials: Using the US Bureau of the Census
database, all studies listed of high qualitywith keywords “refugee,”
“asylum,” “immigrant,’ or “migrant” were collated. From this
cohort, inapplicable and studies were deleted (eg, those listed as
“non-migrants”). The data were analyzed using STATA 11, with
respect to HIV prevalence, median year of collection, sample size,
and age.
Results: There were 645 eligible studies from 40 countries car-
ried out between 1987 and 2015 deemed adequate for analysis.
Most studies were from Asia (70%) or Africa (24%). The overall HIV
prevalence among unsettled populationswas 6.5% (SD 9.8, median,
2.5%).Over the last5years, among446studies, themeanprevalence
was 6.5%. The 151 studies among only females showed a higher
prevalence than those among only males (8.4% vs 6.4%, P =0.43).
The sample size of 95 studies with data ranged from 5 to
930 persons, mean 359 (the mean HIV prevalence for this subset,
11.5%). Studies with a smaller sample size tended to show higher
HIV prevalence (correlation coefﬁcient, -0.52). There was a small
increase in prevalence through time (correlation coefﬁcient, 0.05).
Studies before 2001 had a median prevalence of 7.7% while those
after2001showedamedianprevalenceof6.3%) (P=0.0001,Kruskal
Wallis. Age values were available for only 72 studies, with a mean
prevalence of 10.5%, and slightly increased with age, correlation
coefﬁcient of 0.28. A regression analysis of age, sample size, and
time of study against prevalence had only 24 studies but showed
that only time of study as signiﬁcant (P = 0.009, adjusted R square,
0.57).
Conclusion: These data on globally unsettled populations show
that while studies with small sample size, of females, and of older
age populations show a higher HIV prevalence, the key factor
remains time of study, with a slow increase in HIV prevalence
through the interval analyzed, 1987-2015. With a mean recent
prevalence of 6.5%, it is important that HIV prevention activities
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Mitochondrial dysfunction among HIV-1
infected patients of South India and evaluation
of mitochondrial DNA as a biomarker of
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Background: NRTI class of drugs though they cause mitochon-
drial toxicity, owing to their cost is the preferred class of drugs in
resource-limited settings like India, hence there is a greater need to
identify a novel biomarker of mitochondrial toxicity. In this study
mitochondrial dysfunction was estimated from peripheral blood
mononuclear cells (PBMCs) and the utility of mitochondrial DNA
(mtDNA) as a marker of mitochondrial toxicity was evaluated.
Methods & Materials: In this longitudinal observational study,
40HIV -1 infected patients treatedwithNRTI based regimen and 57
HIV-1 infectedARTuntreatedpatientswere followed for 18months
at an interval of 6 months and data were compared with 24 HIV
uninfected controls. Mitochondrial dysfunction was determined
from mtDNA content by real time PCR, mitochondrial membrane
potential damage (total lymphocyte mlow) by ﬂow cytometry
and ND1gene of mtDNA was sequenced.
Results: Among the HIV infected, mitochondrial dysfunction
was more pronounced in the ART untreated than the treated.
mtDNA content and total lymphocyte mlow (p=<0.0001) were
signiﬁcantly different among the HIV infected than the controls.
Out of the 22 mtDNA variants observed in HIV infected individu-
als, 27% were found to be associated with mitochondrial mediated
pathogenic conditions, distibuted in 10% of on ART and in 8%
of ART untreated . mtDNA content was signiﬁcantly(p<0.0001)
reduced in both the HIV infected groups, ART untreated had
83.3(65.56-113) and treated had 92.53(68.64-126.7), than the
controls(127.5(110.6-167.7)) throughout the follow up, however
it did not differ signiﬁcantly among the HIV infected. Analysis of
mtDNA content in relation to the adverse events, though differed
signiﬁcantly at the ﬁrst (p= 0.014) and second visit (p= 0.029) was
increased in the subsequent visits among the patients symptomatic
for toxicity.
Conclusion: Mitochondrial dysfunction is evident among both
the treated and untreated HIV-1 infected patients of South India.
As mtDNA depletion failed to relate consistently with laboratory
adverse events during the complete follow up, measuring mtDNA
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content in PBMC alone may not be sufﬁcient enough to predict or
monitor changes in NRTI associated mitochondrial toxicity.
http://dx.doi.org/10.1016/j.ijid.2016.02.601
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Pre-exposure Prophylaxis (PrEP): Attitudes,
preferences and risk compensation behavior
among men who have sex with other men
(MSM) in India
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Background: The HIV epidemic in India is concentrated among
High Risk Groups and continues to be high among MSM popula-
tion. Pre-exposure prophylaxis(PrEP) has shown promising results
in recent trials. The potential of PrEP as an effective HIV preventive
strategy among MSM remains to be studied in India.
Methods&Materials: A structured questionnairewas adminis-
tered to MSM selected by snowball sampling technique. Individual
risk behaviours and demographics were categorised as high, mod-
erate and lowrisk forHIVanda composite risk scorewas calculated.
To assess the agreement between calculated and self-perceived
risk, kappa statisticwas used. Bivariate logistic regressionwas used
to ascertain determinants of willingness to use PrEP and to study
the anticipated drift in risk compensation behavior with PrEP use.
Results: Data from the initial 55 respondents of this multi-city
study are analyzed. The average respondents were predominantly
Kothi (31%), found their partners online (83%), had three or more
sexual partners in the previous three months (44%), had anal sex
less than once a month (45%), used condoms all the time while
having anal sex (55%), and considered HIV a risk for them (67%).
There was no agreement between self-perceived risk for HIV and
calculated composite risk (Kappa= -0.2182, p-value>0.05). Major-
ity (87%) reported willingness to use PrEP which was strongly
associated with self-perceived risk of HIV (OR=5.70, p = 0.009).
Willingness to use PrEP remained high even after learning about
the need for concurrent condom use (OR= 10.83, p = 0.009), regu-
lar HIV tests (OR= 30, p = 0.003) and a daily dosing schedule (OR
= 12.19, p =0.007). Individuals with low calculated composite risk
did not showan increase in anticipated risk compensation behavior
with PrEP use (OR=0.23, p = 0.047).
Conclusion: MSM in India show high willingness to use PrEP,
even if they have to use condoms in combination with PrEP, or be
regularly tested for HIV, or have to adhere to a daily dosing sched-
ule. Contrary tomajor concerns, risk compensation behaviorwould
not increase with the advent of PrEP. Our ﬁndings show that PrEP
uptake could be considerable whilst not increasing compensatory
risk behavior among MSM.
http://dx.doi.org/10.1016/j.ijid.2016.02.602
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Health related quality of life of HIV/AIDS
patients on highly active antiretroviral therapy
in Ahmadu Bello University Teaching Hospital
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Background: The advent of Highly Active Antiretroviral
Therapy (HAART) has reduced HIV/AIDS related morbidity and
mortality, so more people with HIV/AIDS live longer. This study
aims to determine the health related quality of life of HIV/AIDS
patients on HAART at Ahmadu Bello University Teaching Hospital
(ABUTH) Zaria.
Methods & Materials: A cross-sectional descriptive study
among 384 HIV patients on HAART at ABUTH was conducted in
April 2015 with the sample obtained by a systematic sampling
process. A structured, interviewer administered questionnaire was
used to assess the health-related quality of life of the respondents
and the data was analyzed using SPSS Version 21. Ethical approval
was obtained from the Ethical review committee while written
informed consent was obtained from all respondents.
Results:Majority of the respondentswere females (64.3%),with
about 50% in stage 1of thedisease, 40% in stage 2 and the remainder
in stage 3. About 55% had CD4 count of 200-500cell/mm3, 34% had
greater than 500cells/mm3 and 11% had less than 200 cells/mm3ˆ.
Only 7.8% of respondents were dependent on Alcohol and smok-
ing while 79.6%were still engaged in paid work.A total of 22.9% of
respondents had lack of energy while 17.2% experienced pain and
15.6% had drug allergy.
Thedomainwith the lowest scorewas thepsychological domain
(5.99),followed by social domain (6.27), physical domain(7.89) and
the socio-demographic domain (38.46) which the domain with
the highest score. There was statistically signiﬁcant relationship
between CD4 count of respondents and their clinical stage (P
<0.0001), but no statistically signiﬁcant relationship between age
and suicidal thoughts, age and suicidal attempt, sex and suicidal
thoughts and between sex and suicidal attempt (p= 0.05)
Conclusion: Majority of respondents had low quality of life in
the psychological, physical and social domains and high quality of
life in the socio-demographic domain of the health related qual-
ity of life (HRQOL). These ﬁndings highlight the need for enhanced
psycho-social support, effective management of symptoms and
a better environment for improving health related quality of life
among people living with HIV/AIDS.
http://dx.doi.org/10.1016/j.ijid.2016.02.603
